Jagannadham Thununguntla, Strategist & Head of Research, SMC Global Securities recommends selling Ranbaxy Laboratories as there are more downsides in the stock and it can head to Rs 250.
first published: Jul 17, 2013 04:49 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.